Prof. Dr.
Şehnaz KARADENİZ

Prof. Dr.
Şehnaz KARADENİZ

Randevu Al
İstanbul Florence Nightingale Hastanesi
    • 2015-
      Demiroğlu Bilim Üniversitesi Tıp Fakültesi 
      Göz Hastalıkları Anabilim Dalı Öğretim Elemanı, Profesör Doktor

      2013-
      İstanbul Florence Nightingale Hastanesi 
      Göz Hastalıkları Anabilim Dalı Profesör Doktor

      2012-2014
      İstanbul Bilim Üniversitesi Tıp Fakültesi 
      Göz Hastalıkları Anabilim Dalı Öğretim Üyesi, Profesör Doktor

      2006-2010
      İstanbul Bilim Üniversitesi Tıp Fakültesi
      Göz Hastalıkları Anabilim Dalı Doçent Doktor

      2005-2013
      Şişli Florence Nightingale Hastanesi
      Göz Hastalıkları Birimi Doçent Doktor 

      2000-2005
      İstanbul Üniversitesi Deneysel Tıp Araştırma Ensitüsü
      Metabolizma ve Diyabet Araştırma ve Uygulama Birimi Göz Hastalıkları Doçent Doktor

      1996-2005
      İstanbul Üniversitesi Deneysel Tıp Araştırma Enstitüsü 
      İmmünoloji Anabilim Dalı, Yüksek Lisans ve Doktora Programları Öğretim Üyesi 

      1994-2000
      İstanbul Üniversitesi, DETAE 
      Metabolizma ve Diyabet Araştırma ve Uygulama Birimi Uzman Doktor

      1994-2005
      İstanbul Üniversitesi İstanbul Tıp Fakültesi
      Çocuk Hastalıkları Kliniği Neonatoloji Anabilim Dalı Konsültan Hekim

      1992-2004
      İstanbul Üniversitesi İstanbul Tıp Fakültesi
      İç Hastalıkları Anabilim Dalı Diabet Bilim Dalı  Konsültan Hekim

      1991-1994
      İstanbul Üniversitesi, İstanbul Tıp Fakültesi 
      Göz Hastalıkları Anabilim Dalı Uzman Doktor

      1987-1991
      İstanbul Üniversitesi, İstanbul Tıp Fakültesi 
      Göz Hastalıkları Anabilim Dalı Araştırma Görevlisi

      1980-1986
      İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi
      Tıp Eğitimi

      • 1996 BlackSeaDiab Medal, Iasi, Romanya
      • 1999 XIIth Congress of the European Society of Ophthalmology, Stokholm, İsveç Santen Poster Prize for Pediatric Ophthalmology, Strabismus and Miscellaneous Karadeniz S. “Screening of retinopathy of prematurity. Should we adjust the upper limits again?”
      • 2002 Ulusal Diyabet Kongresi, İstanbul Türkiye Diyabet Vakfı, Diabetes Mellitus Uluslararası Bilimsel Yayın (Bildiri) Destek Ödülü Karadeniz S, Yilmaz MT. “Age at diabetes onset: Is it one of the determinants for diabetic retinopathy in type 2 diabetes.” Diabetologia 2001; 44(Suppl 1): A286
      • 2006 Ulusal Diyabet Kongresi, Antalya Türkiye Diyabet Vakfı, Diabetes Mellitus Uluslararası Bilimsel Yayın (Bildiri) Destek Ödülü Karadeniz S, Yılmaz MT. “Hypertension: A risk factor for nonproliferative diabetic retinopathy and sight-threatening diabetic maculopathy” EASD Hypertension in Diabetes Study Group Meeting Abstract Book, 2005
      • 2007 Ulusal Diyabet Kongresi, Antalya Türkiye Diyabet Vakfı, Diabetes Mellitus Uluslararası Bilimsel Yayın (Bildiri) Destek İkincilik Ödülü Karadeniz S, Yılmaz MT. “Duration of diabetes at onset of diabetic retinopathy in type 1 and in type 2 diabetic patients” Diabetic Medicine, 2006, 23(Suppl. 4): P2050, 713-714

      • Türk Oftalmoloji Derneği, Retina Birimi
      • Türk Tabipler Birliği
      • Türkiye Diyabet Vakfı (Kurucu Üye)
      • American Diabetes Association (ADA)
      • European Association for the Study of Diabetes (EASD)

      Diğer  
      • 2004-2007 Diyabetle Yaşam Derneği, Genel Başkanı 
      • 2007-2012 International Diabetes Federation Europe (IDF-Europe) Yönetim Kurulu Üyesi
      • 2012-2015 International Diabetes Federation Europe (IDF-Europe) Gelecek Dönem Başkanı
      • 2014-2017 European Association for the Study of Diabetes (EASD) Konsey Üyesi
      • 2015-2019 International Diabetes Federation Europe (IDF-Europe) Başkanı
      • 2018- Türkiye Diyabet Vakfı Yönetim Kurulu Üyesi
      • 2019- Diyabetle Yaşam Derneği Genel Başkanı

  • Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

      KİTAP / KİTAP BÖLÜMÜ YAZARLIĞI

      Yabancı Dilde

      • Health Consumer Powerhouse 2013 Euro Vision Scorecard Report. Eds Hjertqvist J, Björnberg A. External expert panel Banks I, Güell JL, Karadeniz S, Larsen M, Nevin M.  Health Consumer Powerhouse Ltd 2013
      • Yilmaz MT, Karadeniz S. Prediabetes and diabetes prevention initiatives in Turkey. Ch 18. In: Global Health Perspectives in Prediabetes and Diabetes Prevention. Ed: Bergman M. World Scientific Publishing Co. Pte.Ltd. 2014; p.407-30
      • Karadeniz S, Zimmet P,Aschner P, Belton A, Cavan D, Jalang’o A, Gandhi N, Hill L, Makaroff L, Le Mesurier R, Patel B, Porta M, Taylor H.International Diabetes Federation and Fred Hollows Foundation. Diabetes Eye Health. A guide for health care professionals. (Co-chairs: Karadeniz S, Zimmet P.) Brussels, Belgium. International Diabetes Federation 2015
      • Integrating diabetes evidence into practice: Challenges and opportunities to bridge the gaps. Eds: Khunti K, Andriciuc, Karadeniz S, Lalic N, Makrilakis K, Pall N, Quinn L, Saraheimo M, Vlasenko I. CInternational Diabetes Federation Euorope 2017
      b) Türkçe

      • Karadeniz Ş, Ovalı T, Öngör E: Diyabetik retinopati takibinde kullanılan yöntemler. 2. Baskı. In: Diyabetolojiye Giriş Laboratuar ve Klinik Tanı Kriterlerinin Standardizasyonu. Eds: Büyükdevrim AS, Yılmaz MT, Satman İ, Dinççağ N, Karşıdağ K, Altuntaş Y. Fatih Ofset Matbaası, İstanbul. s.117-25, 1996 
      • Akalın S, Aslan M, Başkal N, Çorakçı A, Dinççağ N, Erbaş T, Hatun Ş, İlkova H, İmamoğlu Ş, Karadeniz Ş, Korugan Ü, Özer E, Tuncel E, Yeşil S, Yılmaz C, Yılmaz MT: Diabetes Mellitus 2000. Yılmaz C, Yılmaz MT, İmamoğlu Ş (Eds). Gri Tasarım, İstanbul, 2000  
      • Karadeniz Ş: Diyabetik retinopati ve tedavisi. In: Diabetes Mellitus’un Modern Tedavisi. Yılmaz MT, Bahçeci M, Büyükbeşe A (Eds). Özlem Grafik Matbaacılık, İstanbul. 2004; s.123-128
      • Karadeniz Ş. Diabetik retinopati. İç Hastalıkları Kitabı 1.Cilt. Ed: Büyüköztürk K. Ed. Yard: Atamer T, Dilmener M, Erzengin F, Kaysı A, Ökten A. Nobel Tıp Kitabevi 2007;  s.561-64
      • Karadeniz Ş. Diyabet ve göz. Sorularla Diyabet. Ed: Yılmaz MT. Mart Matbaacılık Sanatları 2008;  s.46-49
      • Diyabet Tanı ve Tedavi Rehberi. Eds: M.T. Yılmaz, A. Kaya, M.K. Balcı, İ. Yetkin, A. Çömlekçi, M. Sargın, E. Özer, Ş. Karadeniz. Portakal  Basım Matbaacılık San. Tic. Ltd. Şti. İstanbul 2011
      • Taşlıpınar A, Çorakçı A, Kaya A, Uysal AR, Tuzcu A, Sönmez A, Kut A, Gemalmaz A, Çıkım Sertkaya A, Atmaca A, Çakır B, Çetinarslan B, İlhan B, Tokgöz B, Gökçe C, Özdemir D, Gogaz Yavuz D, Ural D, Er E, Ertörer E, Orbay E, Özer E, Akal Yıldız E, Karakurt F, Bayraktar F, Sipahioğlu F, Eminsoy G, Kızıltan G, Bilen H, Kahraman H, İlkova H, Onat H, Sebile Dökmetaş H, Gökmen Özel H, Tonbul HZ, Şahin İ, Ünlüoğlu İ, Tarkun İ, Yetkin İ, Marakoğlu K, Kebapçılar L, Yılmaz MT, Sargın M, Çakır M, Kayıkçıoğlu M, Yılmaz M, Girginer M, Şahin M, Kulaksızoğlu M, Cesur M, Araz M, Balcı MK, Kutlu M, Özyazar M, Olgun N, Deyneli O, Azal Ö, Sarı R, Çolak R, Sancak S, Çelik SG, Karadeniz Ş, Yücel T, Özkan Y, Cantürk Z. Ulusal Diyabet Konsensus Grubu, Diyabet Tanı ve Tedavi Rehberi 2016. Türkiye Diyabet Vakfı. Eds: Yılmaz MT, Kaya A, Balcı MK, Bayraktar F, Dağdelen S, Şahin İ, Sargın M. Armoni Nüans Baskı Sanatları A.Ş., İstanbul 2016 
      • Çorakçı A, Kaya A, Tuzcu AK, Akıncı B, Güney E, Akarsu E, Yıldız E, Bayram F, Bayraktar F, Bilen H, İlkova H, Şahin İ, Yetkin İ, Gül K, Karşıdağ K, Yılmaz MT, Sargın M, Ertörer ME, Yılmaz M, Araz M, Balcı MK, Başkal N, Deyneli O, Azal Ö, Sarı R, Çolak R, Dağdelen S, Güllü S, Karadeniz Ş, Bayraktaroğlu T, Sabuncu T, Erbaş T, Altuntaş Y, Oşar Siva Z, Kebapçılar L, Kulaksızoğlu L, Bakıner OS, Alkan İT, Bardakçı AZ, Özkan MA. Ulusal Diyabet Konsensus Grubu, Diyabet Tanı ve Tedavi Rehberi 2018. Türkiye Diyabet Vakfı. Eds: Yılmaz MT, Kaya A, Balcı MK, Karadeniz Ş, Dağdelen S, Şahin İ, Sargın M. Ege Reklam Basım Sanatları San Tic Ltd Şti, İstanbul 2018 

      ULUSLARARASI DERGİLERDE YAYINLANAN MAKALELER

      • Karadeniz S, Kır N, Yılmaz MT, Öngör E, Dinççag N, Başar D, Akarçay K, Satman İ, Devrim AS: Alteration of visual function in impaired glucose tolerance. European Journal of Ophthalmology 1996; 6(1): 59-62

      • Andel M, Bolli BG, Boulton AJM, Bozikov V, Car N, Christov V, Corcos A, Del Prato S, Drzewoski J, Fövenyi J, Hancu N, Hanefeld M, Harman-Boehm I, Heine RJ, İlkova H, İmamoğlu S, Ionescu-Tirgoviste C, Jermendy G, Karadeniz Ş, King H, Koev D, Norkus A, Perusicova P, Ravnik-Oblak M, Raz I, Serban V, Sieradzki J, Skrha J, Sulcaite R, Taton J, Temelkova-Kurktschiev T, Tkac I, Vozar J, Vrhovac B, Vrtovec M, Yılmaz T: Recommendations for the management of patients with type 2 diabetes mellitus in the Central, Eastern and Southern European Region. Consensus Statement. Update, International Journal for Postgraduate Training in Medicine 2000; 8: 3-26
      • Satman I, Yilmaz MT, Gursoy N, Karsidag K, Dinccag N, Ovali T, Karadeniz S, Uysal V, Bugra Z, Otken A, Devrim S: Evaluation of insulin resistant diabetes mellitus in Alstrom syndrome.: a long-term prospective follow-up of three siblings. Diabetes Res Clin Pract 2002; 56(3): 189-196
      • Karadeniz S, Yılmaz MT: Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study-IDRS results 1. Diabetes & Metabolic Syndrome: Clinical Research and Reviews 2007; 1: 43-48
      • Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Hühmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T: A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010; 42 (Suppl 1): S3-S36
      • Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Pölönen A, Rissanen A, Roden M, Stemper T, Telle-Hjellset V, Tuomilehto J, Velickiene D, Schwarz PE, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T: Take action to prevent diabetes-theIMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010; 42 (Suppl 1): S37-S55
      • Pajunen P, Landgraf R, Muylle F, Neumann A, Lindström J, Schwarz PE, Peltonen M, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T: Quality indicators for the prevention of type 2 diabetes in Europe-IMAGE. Horm Metab Res 2010; 42 (Suppl 1): S56-S63
      • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).  Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. Atherosclerosis. 2012 Jul;223(1):1-68. 
      • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012).  Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Avrupa Kardiyoloji Derneği ile Klinik Uygulamada; Kardiyovasküler Hastaliklardan Korunma Üzerinde Çalişan Diğer Derneklerin Beşinci Birleşik Görev Grubu (dokuz derneğin temsilcileri ve davet edilmiş uzmanlardan oluşmaktadir; Avrupa Kardiyovasküler Korunma  and Rehabilitasyon (EACPR); özel Katkisi ile geliştirilmiştir. Turk Kardiyol Dern Ars 2012; 40 (Suppl 3): 1-76 
      • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).  Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Int J Behav Med 2012; 19(4): 403-488
      • Hernandez C, Simo R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (Arce R, Bandello F, Burks D, Cunha-Vaz J, Egan C, Garcia-Arumi J, Gibson J, Harding SP, Karadeniz S, Lang G, Massin P, Midena E, Ponsati B, Porta M, Scanlon P, Simo R, Sjoie AK, Valverde AM). Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 2012; 96(10): 1285-1290
      • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Fifth Joint Task Force of the European Society of Cardiology; European Association of Echocardiography; European Association of Percutaneous Cardiovascular Interventions; European Heart Rhythm Association; Heart Failure Association; European Association for Cardiovascular Prevention & Rehabilitation; European Atherosclerosis Society; International Society of Behavioural Medicine; European Stroke Organisation; European Society of Hypertension; European Association for the Study of Diabetes; European Society of General Practice/Family Medicine; International Diabetes Federation Europe (Karadeniz S); European Heart Network. Eur J Prev Cardiol. 2012 Aug;19(4):585-667
      • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. Eur Heart J. 2012 Jul;33(13):1635-1701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3. No abstract available. Erratum in: Eur Heart J. 2012 Sep;33(17):2126.
      • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).  Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Comitato per Linea Guida Pratiche (CPG) dell’ESC. G Ital Cardiol (Rome) 2013; 14(5): 328-392 
      • Hernandez C, Simo R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (Bandello F, Burks D, Cunha-Vaz J, Egan C, Garcia-Arumi J, Gibson J, Harding SP, Karadeniz S, Lang G, Massin P, Midena E, Ponsati B, Porta M, Scanlon P, Simo R, Sjoie AK, Valverde AM). Somatostatin replacement: a new strategy for treating diabetic retinopathy. Curr Med Chem 2013; 20(26): 3251-3257
      • Simo R, Hernandez C; European Consortium for the Early Threatment of Diabetic Retinopathy (EUROCONDOR) (Bandello F, Burks D, Cunha-Vaz J, Egan C, Garcia-Arumi J, Gibson J, Harding SP, Karadeniz S, Lang G, Massin P, Midena E, Ponsati B, Porta M, Scanlon P, Simo R, Grausland J, Valverde AM). Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 2014; 25(1): 23-33
      • Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, Karadeniz S, Meriden T, Misha’l AA, Pozzili P, Shera S, Thomas A, Bahijri S, Tuomilehto J, Yilmaz T, Umpierrez GE. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care 2015; 3(1): e000108

Video